Radiomics AI Supports Detection of Prostate Cancer
Posted:
Automated radiomics-based artificial intelligence tools are being evaluated as decision-support systems that may assist radiologists in lesion detection and risk assessment while fitting into established prostate cancer diagnostic pathways.
Pharmacy researchers in Hong Kong have developed an AI-driven tool that predicts cardiovascular risks beyond genetics, monitoring near-real-time biological changes before diseases become apparent.
Read more here.
Announcing the official launch of the British College of Cosmetic Surgery, an important new initiative dedicated to strengthening education, collaboration and professional standards within cosmetic surgery.
Read more here.